Abstract:Cancerous microvesicles (MVs), which are heterogeneous membrane-bound nanovesicles shed from the surfaces of cancer cells into the extracellular environment, have been widely recognized as promising "biofingerprints" for various cancers. High-performance identification of cancerous MVs plays a vital role in the early diagnosis of cancer, yet it is still technically challenging. Herein, we report a gold nanoparticle (AuNP)-decorated, dual-aptamer modified reduced graphene oxide (RGO) field-effect transistor (AAP-GFET) nanosensor for the label-free, specific, and sensitive quantification of HepG2 cell-derived MVs (HepG2-MVs). After GFET chips were fabricated, AuNPs were then decorated on the RGO surface. For specific capture and detection of HepG2-MVs, both sulfhydrylated HepG2 cell specific TLS11a aptamer (Apt(TLS11a)) and epithelial cell adhesion molecule aptamer (Apt(EpCAM)) were immobilized on the AuNP surface through an Au-S bond. This developed nanosensor delivered a broad linear dynamic range from 6 x 10(5) to 6 x 10(9) particles/mL and achieved a high sensitivity of 84 particles/mu L for HepG2-MVs detection. Moreover, this AAP-GFET platform was able to distinguish HepG2-MVs from other liver cancer-related serum proteins (such as AFP and CEA) and MVs derived from human normal cells and other cancer cells of lung, pancreas, and prostate, suggesting its excellent method specificity. Compared with those modified with a single type of aptamer alone (Apt(TLS11a) or Apt(EpCAM)), such an AAP-GFET nanosensor showed greatly enhanced signals, suggesting that the dual-aptamer-based bio-nano interface was uniquely designed and could realize more sensitive quantification of HepG2-MVs. Using this platform to detect HepG2-MVs in clinical blood samples, we found that there were significant differences between healthy controls and hepatocellular carcinoma (HCC) patients, indicating its great potential in early HCC diagnosis.

Detection of Hepatoma Serum Marker CD105 with Hemin/Graphene/Aptamer Nanoprobes

Emerging Biomolecules for Practical Theranostics of Liver Hepatocellular Carcinoma.

An Integrated Electrochemical POCT Platform for Ultrasensitive Circrna Detection Towards Hepatocellular Carcinoma Diagnosis.

Hepatocellular Carcinoma Detection by Cell Sensor Based on Anti-GPC3 Single-Chain Variable Fragment

Novel Three-Dimensional Hierarchical Porous Carbon Probe for the Discovery of N-Glycan Biomarkers and Early Hepatocellular Carcinoma Detection.

Dual-Aptamer Modified Graphene Field-Effect Transistor Nanosensor for Label-Free and Specific Detection of Hepatocellular Carcinoma-Derived Microvesicles

An integrated microfluidic cytosensor coupled with self-calibration electrochemical/colorimetric dual-signal output for sensitive and accurate detection of hepatoma cells

Socioeconomic gradients in health for white and Mexican-origin populations.

Noninvasive Detection of Hepatocellular Carcinoma with Circulating Tumor DNA Features and Α-Fetoprotein

Ultrasensitive and Simultaneous SERS Detection of Multiplex MicroRNA Using Fractal Gold Nanotags for Early Diagnosis and Prognosis of Hepatocellular Carcinoma.

CS2 activation at uranium(III) siloxide ate complexes: the effect of a Lewis acidic site.

Novel aptasensor-based assay of sonic hedgehog ligand for detection of portal vein invasion of hepatocellular carcinoma

Ultrasensitive, high-throughput and multiple cancer biomarkers simultaneous detection in serum based on graphene oxide quantum dots integrated microfluidic biosensing platform

A highly sensitive strategy for glypican-3 detection based on aptamer/gold carbon dots/magnetic graphene oxide nanosheets as fluorescent biosensor

Hepatocellular Carcinoma Biomarkers Screening Based on Hydrogel Photonic Barcodes with Tyramine Deposition Amplified ELISA

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma

A Highly-Parallelized and Low-Sample-size Chip for Simultaneous Detection of Protein and Nucleic Acid Biomarkers in Hepatocellular Carcinoma

Detection of two markers for pancreatic cancer (CEA, CA199) based on a nano-silicon sphere-cyclodextrin recognition platform

Simultaneous Detection of Multiplex Biomarkers Related with Hepatocellular Carcinoma by Coupling DNase I-Assisted Recycling Amplification and Microfluidic Electrokinetic Stacking Chip with Parallel Multi-Channels

Glypican-3-targeted precision diagnosis of hepatocellular carcinoma on clinical sections with a supramolecular 2D imaging probe.

Multiple Biomarker Simultaneous Detection in Serum via a Nanomaterial-Functionalized Biosensor for Ovarian Tumor/Cancer Diagnosis